Platinum Sponsors
AstraZeneca
We are a global, science-led, patient-focused pharmaceutical company. We are dedicated to transforming the future of healthcare by unlocking the power of what science can do for people, society, and the planet.
- www.astrazeneca.com
- Booth No. 11
GSK
GSK is focused on maximising patient survival through transformational medicines. Our goal is to achieve a sustainable flow of new treatments in immuno-oncology, tumour cell targeting therapies and synthetic lethality.
- www.gsk.com
- Booth No. 12
ImmunoGen
ImmunoGen is developing the next generation of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. By generating targeted therapies with enhanced anti-tumor activity and favorable tolerability profiles, we aim to disrupt the progression of cancer and offer our patients more good days. We call this our commitment to TARGET A BETTER NOW™.
- www.immunogen.com
- Booth No. 5
MSD
At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than a century, we’ve been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions for the world’s most challenging diseases.
- www.msd.com
- Booth No. 2
Silver Sponsors
Eisai EMEA
At Eisai EMEA, everything we do is dedicated to giving our first thought to patients and their families through our human health care (hhc) philosophy. Eisai’s oncology treatments strive to give cancer patients as much meaningful time as possible, making a difference and positively impacting their lives and those of their families.
- www.eisai.eu
- Booth No. 8
Menarini Stemline
Menarini Stemline is committed to making a difference in cancer patients’ lives. We invest in developing precision medicine through our pipeline of investigational drugs. Partnering with cancer experts and research institutions globally, we aim to improve our outstanding cancer to enable personalized care from early detection to precision medicine.
Mural Oncology
Mural Oncology is a clinical-stage immuno-oncology company leveraging its industry-leading protein engineering platform to reimagine cytokine-based immunotherapies for the treatment of cancer. Mural’s lead candidate, nemvaleukin alfa, is currently in potentially registrational trials in both mucosal melanoma and platinum-resistant ovarian cancer.
- www.muraloncology.com
- Booth No. 4
Bronze Sponsors
Daiichi Sankyo
With more than 120 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 17,000 employees around the world draw upon a rich legacy of innovation to realize our 2030 Vision to become an Innovative Global Healthcare Company Contributing to the Sustainable Development of Society.
pharma&
pharmaand GmbH (pharma&) aspires to breathe new life into proven medicines through an agile and fully integrated business model and aims to guarantee the enduring availability, dependability, and quality of essential drugs worldwide that eligible patients and healthcare providers rely on. Over the past five years, pharma& has acquired 10+ medicines, expanding its portfolio across a wide range of therapy areas, with an increasing focus on hematology and oncology treatments.
Exhibitor
Myriad Genetics
Myriad Genetics is a genetic testing and precision medicine company dedicated to advancing health and well-being for all. In Europe, Myriad offers genomic tests through local testing collaborations that can help personalize and improve cancer care.
- www.myriadgenetics.eu
- Booth No. 15
Societies
European School of Oncology
The European School of Oncology is an independently funded non-profit organisation dedicated to quality education and training. ESO's vision is to ensure that all cancer patients have access to unbiased and evidence-based competent care from adequately trained health professionals. Join ESO and learn more.
- www.eso.net
- Booth No. 16
World Ovarian Cancer Coalition
Established in 2016, the World Ovarian Cancer Coalition is the only global not-for-profit focused on ovarian cancer. Working with close to 200 patient advocacy organizations around the world, the Coalition is determined that everyone living with, or at risk of, ovarian cancer has the best chance of survival and the best quality of life possible, no matter where they live.
- www.worldovariancancercoalition.org
- Booth No. 17
